Metabolite Profiling of Radiolabelled Compounds
Performed in Accordance with FDA Regulatory Guidelines
- FDA ‘Safety Testing of Drug Metabolites’ – Guidance for Industry (November 2016, March 2020)
- ‘Metabolites in Safety Testing’ (MIST) PhRMA Position Paper (April 2016)
